ArticleJournal of gastrointestinal oncology2020

Ramucirumab plus paclitaxel or FOLFIRI in platinum-refractory advanced or metastatic gastric or gastroesophageal junction adenocarcinoma-experience at two centres.

Ursula M Vogl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.